Delivery Order SPE2DR25D2010-SPE2DR26F5BBC
Award Date 4/23/26
Potential Completion Date 4/24/26
Potential Value $1.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,888.71 delivery order to Amerisourcebergen Drug Corp on April 16, 2026, for Repatha 140 mg/ml SureClick pharmaceutical supply, with an ultimate completion date of April 17, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals,...
- The Defense Logistics Agency issued a $12,904.26 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply, with ultimate completion April 20, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to Defense Health...
- The Defense Logistics Agency issued a $3,104.77 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for Repatha 140 mg/ml SureClick autoinjector pharmaceutical supply. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 20, 2026, and is priced on a firm fixed-price basis with no set-aside. The parent vehicle is the DLA Troop Support Medical indefinite delivery contract (SPE2DX series), which supports pharmaceutical distribution to military...
- The Defense Logistics Agency issued a $5,332.43 delivery order to Amerisourcebergen Drug Corp on March 27, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply, with an ultimate completion date of March 30, 2026. The order is issued under a Defense Logistics Agency Indefinite Delivery Contract with Cencora, Inc. (Amerisourcebergen's parent), valued at up to $999,999,999.00 through December 2031, supporting global pharmaceutical supply to military healthcare programs. Place...
- <p>The Defense Logistics Agency issued a $4,347.76 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Repatha 140 mg/ml SureClick autoinjector pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 27, 2026, and is priced on a firm fixed-price basis. No set-aside was used. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc.</p>
- The Defense Logistics Agency awarded a $2,121.30 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on February 4, 2026, with completion expected by February 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $20,649.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 23, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical product, with an ultimate completion date of January 26, 2026. This non-set-aside competitive award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery...
- The Defense Logistics Agency issued a $43,826.76 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for supply of Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 27, 2026, and is priced on a firm fixed-price basis with no set-aside applied. The awardee is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs.
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,971.95 firm fixed-price delivery order from the Defense Logistics Agency on January 15, 2026, for Repatha 140 mg/ml SureClick auto-injectors. The award is unset-aside and competitively awarded, with an ultimate completion date of January 16, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,800.85 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 21, 2026. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F5BBCDelivery Order
The Defense Logistics Agency issued a $1,488.50 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply. Place of performance is Conshohocken, PA. The order closes April 24, 2026. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to federal healthcare systems. The company holds a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million through December 2036 under the Pharmaceutical Prime Vendor Global Program Generation V, supporting worldwide military healthcare supply.
Generated 7/22/26, 11:16 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/22/26 |